Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
A 2018 review detailed multiple positive studies and trials on GHK-Cu for signs of skin aging
In summary, the study demonstrates that FOXO4-DRI effectively eliminates senescent Leydig cells, improves the testicular microenvironment, and alleviates age-related testosterone secretion insufficiency, highlighting its therapeutic potential for male late-onset hypogonadism [1]
No blinded assessment
Invest Ophthalmol Vis Sci 49 , 27992805, (2008)
US$ 29.41
US$ 29.82
US$ 23.55
